Related Experiment Video
Updated: Jun 6, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Helicobacter pylori seropositivity in fibromyalgia syndrome
Nuray Akkaya1, Semih Akkaya, Yusuf Polat
1Department of Physical Medicine and Rehabilitation, Pamukkale University Medical School, Denizli, Turkey. nrakkaya@gmail.com
Abstract:
Although there are some studies suggesting relation between different types of infection and fibromyalgia syndrome (FM), there is presently no proof that FM is caused by an infection. Helicobacter pylori (HP) infection may cause extragastric manifestations. Inflammation is an important mediator of increased sympathetic nervous system activity and may lead to pain in fibromyalgia patients. In this study, we aimed to investigate the HP seropositivity in fibromyalgia patients compared with controls for possible role of HP infection in FM. Sixty-seven patients with fibromyalgia were evaluated. Two of them were excluded from the study because of high level of acute phase reactants. Sixty-five female patients with fibromyalgia and 41 randomly selected age-matched female healthy controls were enrolled to study. Serum HP IgA and IgG antibodies were measured by enzyme-linked immunosorbent assay technique. Fibromyalgia Impact Questionnaire was assessed in patients and controls. Seropositivity of HP IgG antibody in the fibromyalgia patients was significantly higher than in the control group. No statistically significant differences were found regarding the clinical features between fibromyalgia patients with HP IgG antibody and patients without IgG antibody. Our study suggests that former HP infection may have a role in the etiopathogenesis of fibromyalgia syndrome or may act as a triggering factor. However, high seroprevalence of HP in general population and prevalent asymptomatic infection make it difficult to interpret these results for the definite role of HP in FM. Highlighting the pathophysiologic mechanisms of FM will result in more effective treatment regimens.
Insights
Previous Helicobacter pylori (HP) infection may play a role in fibromyalgia syndrome (FM) development. Researchers found higher HP IgG antibody seropositivity in FM patients compared to controls, suggesting a potential link.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Fibromyalgia syndrome (FM) lacks a definitive cause, but infections are being investigated.
- Helicobacter pylori (HP) infection can manifest beyond the gastrointestinal tract.
- Inflammation is implicated in FM pathophysiology and sympathetic nervous system activity.
Purpose of the Study:
- To compare Helicobacter pylori (HP) seropositivity between fibromyalgia patients and healthy controls.
- To explore the potential role of HP infection in the etiopathogenesis of fibromyalgia syndrome.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure serum HP IgA and IgG antibodies.
- Sixty-five female fibromyalgia patients and 41 age-matched female healthy controls were enrolled.
- Fibromyalgia Impact Questionnaire (FIQ) was used for symptom assessment.
Main Results:
- Seropositivity for HP IgG antibodies was significantly higher in fibromyalgia patients compared to controls.
- No significant clinical differences were observed between HP IgG-positive and HP IgG-negative fibromyalgia patients.
- The study noted the high general seroprevalence of HP, complicating interpretation.
Conclusions:
- Former HP infection may be a contributing factor or trigger in fibromyalgia syndrome development.
- Further research is needed to elucidate the precise role of HP in FM.
- Understanding FM's pathophysiology is key to developing effective treatments.
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
